ICD-10-PCS 2027 procedure code
XW053T9Introduction of Melphalan Hydrochloride Antineoplastic into Peripheral Artery, Percutaneous Approach, New Technology Group 9
Short description: Introduce Melphaln Hydrchl in Periph Art, Perc, New Tech 9
Code last changed in FY2024 (effective October 1, 2023). Source: official FY2027 ICD-10-PCS release from CMS. Page updated September 29, 2026. About our data
About XW053T9
XW053T9 is the ICD-10-PCS code for a introduction procedure on the peripheral artery using a percutaneous approach with melphalan hydrochloride antineoplastic (qualifier: new technology group 9). In ICD-10-PCS, introduction means putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.
It doesn't appear in the MS-DRG procedure index, so on its own it doesn't change the DRG assignment.
It was added in FY2024, effective October 1, 2023.
What each character means
- 1. Section
- XNew Technology
- 2. Body System
- WAnatomical Regions
- 3. Operation
- 0Introduction
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
- 4. Body Part
- 5Peripheral Artery
- 5. Approach
- 3Percutaneous
Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach the site of the procedure
- 6. Device / Substance / Technology
- TMelphalan Hydrochloride Antineoplastic
Includes: HEPZATO(tm) KIT (melphalan hydrochloride Hepatic Delivery System)
- 7. Qualifier
- 9New Technology Group 9
Code history
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 2027
- FY2024 (effective 10/1/2023): Added
- No changes since FY2024.
Common questions about XW053T9
Is XW053T9 a valid ICD-10-PCS code for 2027?
- Yes. XW053T9 is valid for inpatient procedures from October 1, 2026 through September 30, 2027.